熱門資訊> 正文
APP、MGNX和CYCC均为盘前输家
2024-05-14 20:25
- Losers: Augmedix (AUGX) -38% reports Q1 results.
- Inotiv (NOTV) -35% report fiscal 2024 second Quarter financial results and host conference call on Wednesday, May 15, 2024.
- Eastside Distilling (EAST) -28% after Q1 earnings release.
- Akoya Biosciences (AKYA) -22% after Q1 earnings release.
- Inspire Veterinary Partners (IVP) -17%.
- INVO Bioscience (INVO) -13%.
- Terran Orbital Corp (LLAP) -10% after Q1 earnings release.
- BuzzFeed (BZFD) -10% after Q1 earnings release.
- Cyclacel Pharmaceuticals (CYCC) -9%.
- TeraWulf (WULF) -7% after Q1 earnings release.
- AGBA Group Holding Limited (AGBA) -9%.
- Tevogen Bio Holdings (TVGN) -7%.
- Nano Nuclear Energy (NNE) -4%.
- Macrogenics (MGNX) -6%.
- AC Immune (ACIU) -8%.
- Intuitive Machines (LUNR) -7% after Q1 earnings release.
- New Gold (NGD) -6% files for mixed shelf offering.
- AEye (LIDR) -7%.
- Lithium Americas Corp (LAAC) -6% after Q1 earnings release.
- StoneCo Ltd (STNE) -7% after Q1 earnings release.
- TMC the metals company (TMC) -5% after Q1 earnings release.
- Applovin Corp (APP) -5%.
More on pre-market losers & stocks.
- MacroGenics: Strong Likelihood Bad News Has Caused Overreaction (Rating Upgrade)
- AppLovin: Remains A 'Strong Buy' After Post-Earnings Surge (SA Quant)
- MacroGenics, Inc. (MGNX) Q1 2024 Earnings Call Transcript
- MacroGenics crashes after mid-stage data for prostate cancer drug
- MacroGenics GAAP EPS of -$0.84 misses by $0.19, revenue of $9.1M misses by $5.76M
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
